Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222af7
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 85M | $129M | -11% | Mar 2026 |
|
| Deerfield Management Company | 60M | $91M | 0% | Mar 2026 |
|
| Citadel Advisors | 58M | $88M | 100% | Mar 2026 |
|
| DLD Asset Management | 55M | $83M | 108% | Mar 2026 |
|
| LMR Partners | 37M | $56M | 37% | Mar 2026 |
|
| Balyasny Asset Management | 35M | $53M | 17% | Mar 2026 |
|
| Tenor Capital Management | 22M | $33M | 102% | Mar 2026 |
|
| Linden Advisors | 20M | $32M | 0% | Dec 2025 |
|
| BlackRock | 19M | $29M | 11% | Mar 2026 |
|
| Wellington Management Company | 19M | $29M | -34% | Dec 2025 |
|
| Lazard Asset Management | 17M | $250k | -30% | Mar 2026 |
|
| Calamos Advisors | 13M | $20M | 1% | Mar 2026 |
|
| State Street Corporation | 12M | $19M | 0% | Dec 2025 |
|
| MacKay Shields | 10M | $16M | 0% | Mar 2026 |
|
| Aristeia Capital | 10M | $15M | 0% | Mar 2026 |
|
| M&G | 7.3M | $11M | 16% | Mar 2026 |
|
| Lord, Abbett & Co | 7.1M | $11M | 58% | Mar 2026 |
|
| FMR | 7.0M | $11M | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 6.7M | $10M | 21390% | Mar 2026 |
|
| Colony | 5.3M | $8.3M | 100% | Dec 2025 |
|
| Advent Capital Management | 5.1M | $7.8M | 2% | Mar 2026 |
|
| Wells Fargo & Company | 5.0M | $7.5M | 238% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 4.7M | $7.1M | -9% | Mar 2026 |
|
| Amundi | 3.5M | $5.2k | 8% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 3.1M | $5.0M | 25% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.8M | 0% | Dec 2025 |
|
| Goldman Sachs Group | 2.5M | $3.7M | 23% | Mar 2026 |
|
| SSI Investment Management | 2.3M | $3.5M | 0% | Mar 2026 |
|
| Royal Bank of Canada | 2.2M | $3.3M | -73% | Mar 2026 |
|
| Union Bancaire Privee, UBP SA | 1.9M | $2.4M | 40% | Mar 2026 |
|
| Barclays | 1.6M | $2.5M | 667% | Dec 2025 |
|
| Bank Of Montreal | 1.3M | $1.9M | 100% | Mar 2026 |
|
| Bank of America Corporation | 980k | $1.5M | 100% | Mar 2026 |
|
| Leucadia National Corporation | 908k | $1.4M | -83% | Mar 2026 |
|
| Kohlberg Kravis Roberts & Co | 760k | $1.1M | 0% | Mar 2026 |
|
| Agf Management | 750k | $1.1M | 0% | Mar 2026 |
|
| Ares Systematic Credit | 500k | $736k | -62% | Mar 2026 |
|
| Palisade Capital Management | 486k | $773k | -3% | Dec 2025 |
|
| Man Group | 180k | $272k | 0% | Mar 2026 |
|
| Calamos Wealth Management | 148k | $224k | 2% | Mar 2026 |
|
| UBS Group | 120k | $181k | 100% | Mar 2026 |
|
| Sei Investments | 105k | $158k | 0% | Mar 2026 |
|
| Morgan Stanley | 94k | $142k | 100% | Mar 2026 |
|
| Nomura Holdings | 85k | $6.4M | 1593% | Mar 2026 |
|
| Branch Banking & Trust Company | 73k | $117k | 0% | Mar 2026 |
|
| Goss Wealth Management | 17k | $17k | 31% | Mar 2026 |
|
| Boussard & Gavaudan Investment Management | 13k | $20M | 100% | Dec 2025 |
|
| Alpine Partners VI | 600.00 | $907k | 100% | Mar 2026 |
|
| Oddo Bhf Asset Management Sas | 374.00 | $567k | 0% | Mar 2026 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Camden Asset Management | Dec 2025 | 48M | $76B |
| Two Sigma Investments | Dec 2025 | 30M | $48M |
| Millennium Management | Dec 2025 | 16M | $25M |
| CSS | Dec 2025 | 3.4M | $5.4M |
| Jpmorgan Chase & Co | Sep 2025 | 2.2M | $3.0M |
| Westwood Holdings | Dec 2025 | 2.0M | $2.0M |
| Wolverine Asset Management | Dec 2025 | 1.9M | $3.0M |
| Invesco | Dec 2025 | 1.5M | $2.4M |
| Lombard Odier Asset Management | Sep 2025 | 73k | $15M |